Bard’s Oncology Device Success Compensates For Weakened Vascular Sales
This article was originally published in The Gray Sheet
Executive Summary
Bard's Power PICC and Triple Lumen PICC peripherally inserted central catheters helped propel the firm's oncology line during the second quarter